Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)

Conclusions: Our study indicate that PER may be efficacious against BTRE as suggested by its mechanism of action and our current knowledge on mechanisms of brain tumor epileptogenicity.Trial Registration Number (TRN): (Prot. n° 0008872.25-06-2019); RS 919/17.
Source: Frontiers in Neurology - Category: Neurology Source Type: research